3 ms·
The reason why Gilead is doing this is because their hepatitis C franchise has already slowed and will likely be much smaller in a few years. Far better to neg
by refurb 8y ago
The reason why Gilead is doing this is because their hepatitis C franchise has already slowed and will likely be much smaller in a few years. Far better to negotiate a deal like this and lock a country into buying your treatment than to lose market share against competitors.